ArticleThe Journal of biological chemistry2014

Targeting the transient receptor potential vanilloid type 1 (TRPV1) assembly domain attenuates inflammation-induced hypersensitivity.

Robyn Flynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.